More on INBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+2.7% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inhibrx Inc. (NQ:INBX)
Delayed: 93.09 +0.89 (0.97%)
Prev. Close $92.20  
Open$95.12 
52 Wk High$ 
52 Wk Low$ 
Day High$96.09 
Day Low$92.53 
P/E N/A  
EPS$ 
Volume181,073 

Friends, Peers and Foes (?): ACET, ACRV, ARVN, AZN, BCAB (more...)

Jun 15, 2026 09:15 AM Inhibrx receives FDA acceptance for ozekibart drug application
Jun 15, 2026 09:15 AM Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: Vuori Kristiina MD
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: Kayyem Jon Faiz
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: FORSYTH DOUGLAS
Jun 4, 2026 05:29 PM Form 4 Inhibrx Biosciences, For: Jun 03 Filed by: MANHARD KIMBERLY
Jun 3, 2026 04:02 PM Form 8-K Inhibrx Biosciences, For: Jun 03
Jun 2, 2026 07:10 AM Inhibrx Biosciences (INBX) Reiterated at Buy by Stifel After Ozekibart Data Presentation
May 15, 2026 05:52 PM Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2026 04:00 PM Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
View All Articles

Entities mentioned with INBX

View All Entities